June 11, 2015

SNMMI: FDOPA-PET/MRI monitors pediatric brain tumors

Clinicians may soon be able to add PET/MRI with F-18 fluorodopa (FDOPA) to their imaging arsenal to evaluate the efficacy of the angiogenesis inhibitor bevacizumab for pediatric brain tumors, according to a study presented on Monday at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting. {read more here}